Tian Qingzhong, Wang Yun, Guo Hao, Xie Guangwei, Li Jin, Zhang Minkang, Zhang Qianjin, Meng Qingliang
Department of Oncological Surgery 2, Xuzhou City Central Hospital, the affiliated Hospital of the Southeast University Medical School (Xu zhou), the Tumor Research Institute of the Southeast University (Xu zhou), Xuzhou Jiangsu 221009, China.
J BUON. 2017 Mar-Apr;22(2):295-300.
Breast cancer is the leading cause of cancer related deaths in women and one of the most common cancers globally. The major obstacle in the management of breast cancer, especially at advanced stages, is metastasis. Metastasis in the advanced stages of breast cancer could decrease survival to approximately 5 years. The reasons could include lack of targeted receptors or chemotherapeutic agents for the management of advanced-stage breast cancer metastasis. The new emerging avenues for the management of this deadly pathological state include local manipulations like radiofrequency ablation (RFA), microwave thermotherapy, cryosurgery (cryotherapy), chemoembolization, radioembolization, breast surgery, or metastasectomy. Few single-institution reports showed improved survival in selected patients like those with oligometastatic stage IV breast cancer. The present review article focused on these emerging new multimodality treatment approaches for a possible efficient management.
乳腺癌是女性癌症相关死亡的主要原因，也是全球最常见的癌症之一。乳腺癌治疗，尤其是晚期治疗的主要障碍是转移。乳腺癌晚期的转移会使生存率降至约5年。原因可能包括缺乏用于治疗晚期乳腺癌转移的靶向受体或化疗药物。治疗这种致命病理状态的新出现途径包括局部操作，如射频消融（RFA）、微波热疗、冷冻手术（冷冻疗法）、化学栓塞、放射性栓塞、乳房手术或转移灶切除术。少数单机构报告显示，在某些患者中，如寡转移的IV期乳腺癌患者，生存率有所提高。本综述文章重点关注这些新出现的多模态治疗方法，以期实现可能的有效管理。
